Multiplex Assay Kit for Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD121a; CD121-A; IL1-R1; IL1R; IL1RA; P80; CD121 Antigen-Like Family Member A; Interleukin-1 Receptor Alpha

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 86-101 94
EDTA plasma(n=5) 78-99 91
heparin plasma(n=5) 96-103 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-99% 78-91% 80-89% 95-103%
EDTA plasma(n=5) 81-97% 82-92% 80-97% 80-88%
heparin plasma(n=5) 95-103% 93-101% 91-99% 85-92%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:IL1R1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clinical & Experimental Immunology In vivo extravasation induces expression of IL-1R1 in human neutrophils Wiley: source
PLos One The Gene Expression Analysis of Blood Reveals S100A11 and AQP9 as Potential Biomarkers of Infective Endocarditis Plosone: 0031490
Journal of Clinical Apheresis Kinetics of the soluble IL-1 receptor type I during treatment with an LCAP filter in patients with inflammatory bowel disease PubMed: 22267087
PLoS ONE A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches Plosone: Source
中国当代儿科杂志 IL1R1 基因多态性与儿童哮喘的相关性 article:13877
STEM CELLS AND DEVELOPMENT IL-1α regulates osteogenesis and osteoclastic activity of dental follicle cells via JNK and p38 MAPK pathways Pubmed: 33107399
Journal of Integrative Medicine Salvadora persica extract attenuates cyclophosphamide-induced hepatorenal damage by modulating oxidative stress, inflammation and apoptosis in rats Pubmed:35643766
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA066Hu03 Recombinant Interleukin 1 Receptor Type I (IL1R1) 8.35
RPA066Hu02 Recombinant Interleukin 1 Receptor Type I (IL1R1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA066Hu01 Recombinant Interleukin 1 Receptor Type I (IL1R1) Positive Control; Immunogen; SDS-PAGE; WB.
APA066Hu01 Active Interleukin 1 Receptor Type I (IL1R1) Cell culture; Activity Assays.
PAA066Hu02 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1) WB; IHC; ICC; IP.
PAA066Hu03 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1) WB; IHC; ICC; IP.
PAA066Hu01 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1) WB,IHC
LAA066Hu71 Biotin-Linked Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1) WB; IHC; ICC.
MAA066Hu22 Monoclonal Antibody to Interleukin 1 Receptor Type I (IL1R1) WB; IHC; ICC; IP.
SEA066Hu ELISA Kit for Interleukin 1 Receptor Type I (IL1R1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA066Hu Multiplex Assay Kit for Interleukin 1 Receptor Type I (IL1R1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.